Stroke Trial, Recruiting NCT06471127 Sponsor: University of Wisconsin, Madison Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06471127
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 40 and 90
  • People who were right-handed before their stroke
  • People who speak English well
  • People who have had a single ischemic stroke (a stroke caused by a blocked blood vessel) in a specific area of the brain called the middle cerebral artery territory, on either the left or right side of the brain
  • People who have difficulty with language or communication as a result of their stroke (this applies to certain parts of the study)
  • People who are able to understand what the study involves and agree to take part
  • People whose stroke is recent (acute or subacute) for one part of the study, or whose stroke happened at least 12 months ago (chronic) for other parts of the study
  • People who are in a stable medical condition

Who may not be able to join:

  • People with a significant medical or neurological condition other than their stroke
  • People with a significant psychiatric condition, or one that is not well managed
  • People currently misusing alcohol or drugs, including prescription medications
  • People with serious vision or hearing loss that cannot be corrected with glasses or hearing aids
  • People receiving treatments beyond standard stroke care — for example, medications not typically used after stroke (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Haley Dresang, PhD, University of Wisconsin, Madison

Phone: (608) 890-0628

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 March 2025
Est. completion
31 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Aphasia presence/severity; Semantic processing; Phonological processing; Noun processing; Verb processing; Pseudoword learning; Verbal learning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov